Live Breaking News & Updates on Joshuak Sabari|Page 2

Stay updated with breaking news from Joshuak sabari. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

LY3537982 Demonstrates Tolerability and Preliminary Efficacy in KRAS G12C–mutated Advanced Solid Tumors

Joshua K. Sabari, MD, shares how the unique pharmacokinetics and mechanism of action for LY3537982 supported its investigation in the LOXO-RAS- 20001 study, findings presented at AACR, and how this research could address unmet needs in patients with KRAS G12C–mutant solid tumors. ....

New York , United States , Joshuak Sabari , Department Of Medicine , Grossman School Of Medicine , Langone Health Perlmutter Cancer Center , Perlmutter Cancer Center , Mechanism Of Action For Ly3537982 , Loxo Ras 20001 Study , Patients With Kras G12c Mutant Solid Tumors ,